Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (291-300 of 528) with videos related to

Pageof 53
Sort By:
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.
Journal of Clinical Medicine|July 19, 2019
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial BiologyIsa Mambetsariev, Tamara Mirzapoiazova, Frances Lennon, et al.
Cancer Medicine|March 18, 2021
Disparate outcomes in nonsmall cell lung cancer by immigration statusBrittney Chau, Philip Hg Ituarte, Ashwin Shinde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunityTaylor Sittler, Jun Zhou, Joosang Park, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Cureus|April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database InitiativeBrian Won, George B Carey, Yi-Hung Carol Tan, et al.
Anti-Cancer Drugs|September 4, 2008
Protein kinase C beta in malignant pleural mesotheliomaLeonardo Faoro, Sivakumar Loganathan, Maria Westerhoff, et al.
Seminars in Cancer Biology|November 21, 2020
Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant diseaseParvez Khan, Jawed Akhtar Siddiqui, Shailendra Kumar Maurya, et al.
Journal of Angiogenesis Research|March 20, 2010
Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsPatrick A Singleton, Nurbek Mambetsariev, Frances E Lennon, et al.
Carcinogenesis|July 25, 2024
Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporterB Madhu Krishna, Sravani K Ramisetty, Pankaj Garg, et al.
Pageof 53

Showing results (291-300 of 528) with videos related to

Sort By:
Pageof 53
Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.
Journal of Clinical Medicine|July 19, 2019
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial BiologyIsa Mambetsariev, Tamara Mirzapoiazova, Frances Lennon, et al.
Cancer Medicine|March 18, 2021
Disparate outcomes in nonsmall cell lung cancer by immigration statusBrittney Chau, Philip Hg Ituarte, Ashwin Shinde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunityTaylor Sittler, Jun Zhou, Joosang Park, et al.
Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.
Cureus|April 20, 2016
The Chicago Thoracic Oncology Database Consortium: A Multisite Database InitiativeBrian Won, George B Carey, Yi-Hung Carol Tan, et al.
Anti-Cancer Drugs|September 4, 2008
Protein kinase C beta in malignant pleural mesotheliomaLeonardo Faoro, Sivakumar Loganathan, Maria Westerhoff, et al.
Seminars in Cancer Biology|November 21, 2020
Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant diseaseParvez Khan, Jawed Akhtar Siddiqui, Shailendra Kumar Maurya, et al.
Journal of Angiogenesis Research|March 20, 2010
Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsPatrick A Singleton, Nurbek Mambetsariev, Frances E Lennon, et al.
Carcinogenesis|July 25, 2024
Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporterB Madhu Krishna, Sravani K Ramisetty, Pankaj Garg, et al.
Pageof 53